BlossomHill Therapeutics, Inc. (BLSM) stock
BLSMNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026
$15.13+1.48 (+10.84%)
Close on Nov 17, 2026Market cap $38.56MP/E –Yield –
BlossomHill Therapeutics cash
Cash and short-term investments held at the end of each period.
BlossomHill Therapeutics's cash was $95.38M at Jun 30, 2026. For fiscal 2025 it was $136.68M, up 36.5% from the year before.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $136.68M | +36.5% |
| FY2024 | Dec 31, 2024 | $100.15M | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $95.38M | – |
| Q4 FY2025 | Dec 31, 2025 | $136.68M | – |
| Q2 FY2025 | Jun 30, 2025 | $79.11M | – |
| Q4 FY2024 | Dec 31, 2024 | $100.15M | – |
See a number that looks wrong?